<DOC>
	<DOCNO>NCT00705263</DOCNO>
	<brief_summary>The current gold standard treatment chronic hepatitis C pegylated interferon plus ribavirin . Drug administration accuracy ease use definitely determine treatment effectiveness . This idea behind development usage PegIntron pen ( PegPen ) . Therefore , worthwhile evaluate patient ' satisfaction novel device . The result study use improve PegPen train technique patient health care provider .</brief_summary>
	<brief_title>Satisfaction Patients Receiving PegIntron Pen Plus Rebetol Hepatitis C ( Study P04244 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients chronic hepatitis C treat PegIntron pen plus Rebetol Not willing participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>